KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710 | +45.8% | 51,088 | +141.2% | 0.06% | +24.5% |
| Q2 2023 | $487 | +46.7% | 21,184 | +59.3% | 0.05% | +19.5% |
| Q4 2022 | $332 | -99.9% | 13,301 | +10.8% | 0.04% | +17.1% |
| Q3 2022 | $261,000 | -55.7% | 12,008 | -59.9% | 0.04% | -60.2% |
| Q2 2022 | $589,000 | +131.9% | 29,922 | +398.5% | 0.09% | +158.8% |
| Q1 2022 | $254,000 | -85.5% | 6,002 | -78.3% | 0.03% | -84.6% |
| Q4 2021 | $1,757,000 | – | 27,672 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |